Antonio R. Nakasato
East Hanover, Jersey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Effectiveness and Safety of Retreatment with 177Lu-DOTATATE in Patients with Progressive Neuroendocrine Tumors: A Retrospective Real-World Study in the United States.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: April 27, 2023
Risk tolerance in adjuvant and metastatic melanoma settings: a patient perspective study using the threshold technique.
Journal: Future oncology (London, England)
Published: March 12, 2021
Economic Burden of Adverse Events Associated with Immunotherapy and Targeted Therapy for Metastatic Melanoma in the Elderly.
Journal: American health & drug benefits
Published: January 17, 2019
Stage III melanoma incidence and impact of transitioning to the 8th AJCC staging system: a US population-based study.
Journal: Future oncology (London, England)
Published: October 16, 2018
Patterns of treatment and BRAF testing with immune checkpoint inhibitors and targeted therapy in patients with metastatic melanoma presumed to be BRAF positive.
Journal: Melanoma research
Published: September 25, 2018
Postsurgical treatment landscape and economic burden of locoregional and distant recurrence in patients with operable nonmetastatic melanoma.
Journal: Melanoma research
Published: September 15, 2018
Healthcare resource utilization in patients with metastatic melanoma receiving first-line therapy with dabrafenib + trametinib versus nivolumab or pembrolizumab monotherapy.
Journal: Current medical research and opinion
Published: July 17, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026